OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ANL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Adlai Nortye (ANL) Ownership - Who owns Adlai Nortye?

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

685 US Highway 1

Phone

+1 848 230-7430

Employees

N/A

Web

https://www.adlainortye.com

Details

Group

Domestic Stock Funds

Fundamentals

ANL

Capitalization

54.2M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

98M

Total Cash/Share

2.66

Total Debt

39.5M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

53.4M

P/B Ratio

2.13

Cash Flow

N/A

Earnings

-6.18

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

11K

Current Ratio

1.85

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-49.89M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-62.08

Shares Held By Institutions

23.7K

Shares Outstanding - Current

36.9M

Total Liabilities

54.3M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-45.255

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology